Back to company

Biologik ApS: Financial statements 2023

CVR: 36070498

Biologik ApS (CVR 36070498) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 653,018 and a net result of DKK 118,661 compared with DKK -89,361 the year before. That is an increase of 153% compared with the year before. Equity amounted to DKK 329,327. The solvency ratio was 71.1%. The company had 1 employee in the financial year.

Gross Profit
653,018 kr.
Profit/Loss
118,661 kr.
Equity
329,327 kr.
Total Assets
463,092 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-653 t.119 t.329 t.1
2022-258 t.-89 t.268 t.1
2021-593 t.215 t.414 t.1
2020-378 t.62 t.199 t.1
2019-832 t.183 t.237 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

About Biologik ApS

Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity amounted to DKK 408,578.